NasdaqCM - Nasdaq Real Time Price USD
CNS Pharmaceuticals, Inc. (CNSP)
1.0400
+0.0300
+(2.97%)
At close: June 6 at 4:00:01 PM EDT
1.0499
+0.01
+(0.95%)
After hours: June 6 at 7:47:37 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. John Michael Climaco Esq., J.D. | CEO, President & Director | 810.86k | -- | 1969 |
| Mr. Christopher S. Downs CPA, CTP, FP&A | Chief Financial Officer | 474.64k | -- | 1978 |
| Dr. Sandra L. Silberman M.D., Ph.D. | Chief Medical Officer | 288.44k | -- | 1955 |
| Dr. Waldemar Priebe Ph.D. | Founder | -- | -- | -- |
| Dr. Donald H. Picker Ph.D. | Chief Science Officer | -- | -- | 1946 |
CNS Pharmaceuticals, Inc.
2100 West Loop South
Suite 900
Houston, TX 77027
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 4
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Corporate Governance
CNS Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 12, 2025 at 8:00 PM UTC - August 18, 2025 at 8:00 PM UTC
CNS Pharmaceuticals, Inc. Earnings Date
Recent Events
Related Tickers
AZTR Azitra, Inc.
0.2751
+0.22%
APVO Aptevo Therapeutics Inc.
4.9500
+3.56%
VRPX Virpax Pharmaceuticals, Inc.
0.2440
+1.67%
MBRX Moleculin Biotech, Inc.
0.6700
-2.91%
KZIA Kazia Therapeutics Limited
5.65
+1.71%
WINT Windtree Therapeutics, Inc.
0.5681
-3.22%
SLRX Salarius Pharmaceuticals, Inc.
0.7225
-5.17%
ADTX Aditxt, Inc.
1.5400
+6.94%
CDT Conduit Pharmaceuticals Inc.
2.6900
-0.37%
CDIO Cardio Diagnostics Holdings, Inc.
4.7650
+5.42%